Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury
Daryl J. Kor(Mayo Clinic), Michelle N. Gong, Pauline K. Park(University of Michigan), Valerie Banner‐Goodspeed(Beth Israel Deaconess Medical Center), Ognjen Gajic(Mayo Clinic), Daniel Talmor(Harvard University), Richard Hinds(Mayo Clinic), Rickey E. Carter(Mayo Clinic in Florida)
Cited by 60
Related Papers
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram
|Nature Medicine|2018|1.3k
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data
|The Lancet Respiratory Medicine|2016|627
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
|Bristol Research (University of Bristol)|2021|589